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ReplicationDNA topoisomerases pass DNA strands through each other, a function essential for all DNA metabolic processes
that create supercoils or entanglements of DNA. Topoisomerases play an ambivalent role in nuclear genome
maintenance: Deﬁciency compromises gene transcription, replication and chromosome segregation, while the
inherent DNA-cleavage activity of the enzymes endangers DNA integrity. Indeed, many DNA-damaging
agents act through enhancing topoisomerase DNA cleavage. Mitochondrial DNA (mtDNA) clearly requires
topoisomerase activity for transcription and replication, because it is a closed, double-stranded DNA molecule.
Three topoisomerases have so far been found in mammalian mitochondria (I, IIβ, IIIα), but their precise role in
mtDNAmetabolism, mitochondrial maintenance and respiratory function remainsmostly unclear. It is a reason-
able surmise that these enzymes exhibit similar ambiguity with respect to genome maintenance and gene
transcription as their nuclear counterparts. Here, we review what is known about the physiological roles of
mitochondrial topoisomerases and draft three scenarios of how these enzymes possibly contribute to ageing-
relatedmtDNA attrition and respiratory chain dysfunction. These scenarios are: mtDNA attrition by exogenously
stimulated topoisomerase DNA cleavage, unbalancing ofmitochondrial and nuclear transcription bydirect effects
on mitochondrial transcription, and contributions to enhanced mtDNA entanglement and recombination.
© 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license.1. Physiological functions of mitochondrial topoisomerases
HumanmtDNA is a closed, double-stranded DNA circle (Iborra et al.,
2004; Lawrence et al., 1996), although more complex topological
structures are found in certain post-mitotic tissues of aged humans
(Pohjoismaki and Goffart, 2011). A recent survey of the topology of
mammalian mtDNA has revealed more than 25 distinct topological
forms of mtDNA also including DNA/RNA hybrids and variety of single
strandedDNAmolecules (Kolesar et al., 2013). Strand separation during
transcription and replication of the closed double strandedmtDNA form
creates topological stress that interferes with these processes unless
that stress is released in a timely fashion. The only enzymes capable
of performing this task are topoisomerases (Wang, 2002). Three
topoisomerases have been found in mammalian mitochondria, two
enzymes catalysing the transient cleavage and ligation of single strand-
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. Open access under CC BY-NC-SA licecatalysing cleavage and ligation of both strands of the DNA double
helix (mitochondrial topoisomerase IIβ). All three enzymes are encoded
in the nuclear genome. Currently, very little is known about the role of
these enzymes in mtDNA metabolism and maintenance. However, it
appears that their biological functions differ markedly from those of
the corresponding enzymes in the cell nucleus.
Mitochondrial topoisomerase I (TOP1MT) is the only known
mitochondrial topoisomerase encoded by a separate gene. Splitting of
the TOP1 gene into nuclear and mitochondrial paralogs is highly con-
served in vertebrates (Zhang et al., 2001, 2004, 2007) and reﬂects a
functional specialisation: Nuclear TOP1 is incompatible with mtDNA
transcription/replication, while TOP1MT is unable to interact with
nuclear chromosomes (Dalla Rosa et al., 2009). TOP1MT catalyses the
transient cleavage and ligation of one strand of the DNA double helix,
thereby providing themajor activity for relaxation ofmtDNA supercoils.
TOP1MT DNA-cleavage activity is clustered in an mtDNA region down-
stream of the displacement loop (D-loop) (Zhang and Pommier, 2008)
that contains an additional DNA strand (7S DNA). 7S DNA is either a
prerequisite or a side product of mtDNA replication (Falkenberg et al.,
2007). Depletion of 7S DNA upon inhibition of TOP1MT (Zhang and
Pommier, 2008) suggests an involvement of the enzyme in D-loop
maintenance or replication. However, an essential role of TOP1MT
in mtDNA maintenance is unlikely, since TOP1MT−/− mice express
mtDNA-encoded proteins (Douarre et al., 2012). In the cell nucleus,
TOP1 is an essential cofactor promoting rRNA- and mRNA transcription
(Christensen et al., 2002a; Kretzschmar et al., 1993; Zhang et al., 1988).
In mitochondria, TOP1MT is not essential for mtDNA-transcription. Onnse.
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function is not linked to the mito-biogenic nuclear programme,
indicating a direct, intra-mitochondrial regulation mechanism (Sobek
et al., 2014). The negative impact of TOP1MT on mtDNA transcription
involves a direct interaction with mitochondrial RNA polymerase and
probably the removal of supercoils from mtDNA, as it is dependent on
catalytic activity (Sobek et al., 2014). DNA supercoiling is a known
requirement for transcription initiation in bacteria and yeast (Drolet,
2006; Schultz et al., 1992). mtDNA harbours a certain base line level of
supercoiling (Kolesar et al., 2013), which is most probably created in
the course of compaction by mitochondrial transcription factor A
(TFAM) (Kaufman et al., 2007; Pohjoismaki et al., 2006). TFAM-
mediated mtDNA compaction and bending is required for the assembly
of transcription complexes (Hallberg and Larsson, 2011). TOP1MT
possibly counteracts mitochondrial transcription initiation by reducing
supercoiling below the level that permits optimal transcription.
TOP1MT is up regulated in cellular stress responses (Goto et al., 2006)
and cancer cells (Zoppoli et al., 2011) suggesting an involvement in
stress-adaptation of respiratory capacity and the Warburg effect.
However, this seems not the only function: TOP1MT−/−murine embry-
onic ﬁbroblasts (MEFs) exhibit a complex pattern of mitochondrial
dysfunction including hyper-fusion and constitutive retrograde activa-
tion of the nuclear mito-biogenic programme(Douarre et al., 2012).
The mitochondrial dysfunctions of TOP1MT−/− MEFs cannot be
abolished by expressing TOP1MT (Sobek et al., 2014) indicating an es-
sential and constitutive role of the enzyme inmtDNAmaintenance dur-
ing development, which is possibly related to the principal ability of
TOP1 to process RNA/DNA hybrids, suppress R-loops (Tuduri et al.,
2009) and stabilise circular mini-chromosomes (Trigueros and Roca,
2001).
Mitochondrial topoisomerases IIIα (TOP3A) is created by alternative
translation initiation of a common transcript coding for nuclear and
mitochondrial representatives of the enzyme (Wang et al., 2002).
Currently, it is not known how alternative translation of TOP3A is regu-
lated to control the relative amounts of nuclear and mitochondrial
isoforms made from the common transcript. In the nucleus TOP3A
acts on single stranded DNA transiently disengaged from the double
helix (DNA solenoids) and plays an essential role in nuclear transcription
by resolving DNA solenoids formed upon strand separation (Wang,
2002). TOP3A seems to be a sufﬁcient topoisomerase co-factor of
mtDNA transcription, inasmuch as it is capable of upholding base line
levels of mitochondrial transcripts in the absence of TOP1MT and TOP2B
(Sobek et al., 2014). TOP3A deﬁciency causes a depletion of mtDNA in
male germ-line stem cells of Drosophila (Wu et al., 2010) pointing to an
essential role in mtDNAmaintenance, which is possibly linked to its pre-
sumed interactionwith Twinkle helicase (see: section 2.3). However, cur-
rently it is not clear which functional deﬁcit(s) cause this phenotype and
whether it is due to deﬁciency of nuclear ormitochondrial products of the
TOP3Agene.Moreover, the relevance of thisﬁndingwith respect tomam-
malian mtDNA maintenance is questionable, since the machinery
supporting these functions is very different in insects.
Topoisomerase IIβ (TOP2B) is the only known type II topoisomerase
present inmitochondria, which is able to catalyse cleavage, passage and
ligation of both strands of the DNA double helix. In the cell nucleus,
TOP2B plays an essential role in transcriptional activation (Haffner
et al., 2010; Ju et al., 2006) or repression (Tiwari et al., 2012) of certain
gene loci, while chromosome condensation and segregation is exclu-
sively supported by the other isoform topoisomerase IIα (TOP2A)
(Grue et al., 1998; Linka et al., 2007). Mammalianmitochondria contain
a proteolytic derivative of TOP2B, which lacks the entire N-terminal
domain of the enzyme (Low et al., 2003). The N-terminal domain is
the portionmost divergent between TOP2A and TOP2B. It is responsible
for recruiting TOP2B and TOP2A to isoform-speciﬁc tasks (Linka et al.,
2007) but is dispensable for the enzymes' basic catalytic activities
(Jensen et al., 1996). Therefore, the N-terminally truncated, mitochon-
drial form of TOP2B is expected to be fully active in terms of cleavage,passage and ligation of DNA double strands, and could in principle be
the enzyme separating intertwinedmtDNAmolecules that are inadver-
tently formed during replication (Wang, 2002). However this seemsnot
to be the case, since the degree of mtDNA-intertwining as well as the
rate of mtDNA-transcription are normal in TOP2B−/− MEFs. Conse-
quently, there must exist another enzyme activity in mitochondria
that catalyses the separation of intertwined mtDNA molecules
(see also section 2.3). We recently observed that TOP2B is signiﬁcantly
up-regulated in TOP1MT−/−MEFs and capable ofmaintaining increased
levels of mtDNA transcription in the absence of TOP1MT (Sobek et al.,
2014), which possibly indicates a redundant role in the removal of
negativeDNA supercoils that are generated duringmtDNA transcription
and normally removed by TOP1MT.2. Possible contributions of topoisomerases to age-related
alterations in mtDNA homeostasis
2.1. mtDNA attrition by chronic exogenous “poisoning” of mitochondrial
TOP1 and TOP2
Many compounds induce breaks in the DNA backbone through
interference with the cleavage/ligation reaction of TOP1 and/or TOP2.
Such compounds attenuate the ligation step of topoisomerases and
thereby prolong the half-life of a catalytic intermediate consisting of a
DNA break with topoisomerase covalently attached to the free 3′- or
5′-phosphate of the break. Such topoisomerase-linked DNA breaks are
not readily recognised as DNA damage and consequently are less
efﬁciently repaired than other DNA breaks (Deweese and Osheroff,
2009a; Pommier et al., 2006; Soubeyrand et al., 2010). Substances in-
ducing DNA breaks by inhibiting the ligation step of TOP1 or TOP2 are
termed topoisomerase poisons because they turn the entire topoisom-
erase complement of a cell into a DNA-damaging agent. Topoisomerase
poisons encompass a large and heterogeneous group of chemical
compounds.Manywidely prescribed anti-cancer drugs act by poisoning
mammalian TOP2. These include the podophyllotoxins etoposid (VP16)
and teniposide (VM26), the anthracyclins doxo- and daunorubicine, the
phenathraceneMitoxantrone and the aminoacridinem-Amsacrine (Liu,
1989; Nitiss, 2009; Pommier et al., 2010). TOP2 is also poisoned by
various natural alkaloids produced by fungi or plants. Typical examples
are the plant alkaloid Lycobetain (Barthelmes et al., 2001) and the
fungal toxin Alternariol, which is a frequent carcinogenic food contam-
inant (Fehr et al., 2009). TOP2 poisoning is also an established carcino-
genic mechanism of 1,4-benzoquinone metabolites derived from
industrial waste products containing benzene (Lindsey et al., 2005).
Interestingly the widely prescribed analgesic drug Acetaminophen is
likewise metabolised to a 1,4-benzoquinone derivative that effectively
poisons mammalian TOP2 and possibly triggers liver carcinogenesis in
humans (Bender et al., 2004). Moreover, certain bioﬂavonoids that are
constituents of normal human diet exhibit a strong TOP2-poisoning
activity. Most notably, the isoﬂavone Genistein contained in soybeans
is a strong poison of TOP2B (Bandele and Osheroff, 2007). Habitual
consummation of soy-based dietary supplements or food fortiﬁed
with isoﬂavones in puriﬁed form is assumed to raise serum levels of
Genistein up to 10 μM (Nielsen andWilliamson, 2007), a concentration
that effectively poisons TOP2B in cultured human cells (Kalfalah et al.,
2011). It is assumed that Genistein consumed at high doses during
pregnancy plays a role in triggering infant leukaemia (Ross, 2000;
Ross and Kasum, 2002). Poisoning of TOP1 is the established mecha-
nism of a group of widely prescribed anti-cancer drugs derived
from the plant alkaloid camptothecin (Nitiss, 2009; Pommier et al.,
2010). TOP1-poisoning is also a side effect of the Dihydropyridine
Dexniguldipine, a drug prescribed as a calcium antagonist (Straub
et al., 1997). The isoﬂavone Quercetin contained in nuts and coffee is
an effective TOP1-poison (Boege et al., 1996). Genistein is highly
enriched in certain food supplements, but it is not known whether its
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induce TOP1-poisoning in humans.
In addition to the above chemical compounds, various exogenously
induced DNA base modiﬁcations can inhibit the ligation step of TOP1
or TOP2 in vitro, when placed next to a strong cleavage site in a synthet-
ic DNA substrate (Deweese and Osheroff, 2009b; Kingma and Osheroff,
1998; Leteurtre et al., 1994; Pourquier et al., 1997, 2000; Sabourin and
Osheroff, 2000; Yeh et al., 1994). Thus, ephemeral DNA lesions such as
base oxidations or abasic sites that are normally rapidly removed can
trigger topoisomerase-linked breaks in the DNA backbone that are not
or only slowly repaired. In live mammalian cells, topoisomerase-
coupled DNA breaks are indeed induced next to oxidised DNA bases
(e.g. 8-oxo-guanine), and enhanced DNA-oxidation increases the
formation of TOP1- or TOP2-linked DNA breaks and/or results in the
immobilisation of the enzymes on nuclear DNA (Daroui et al., 2004;
Lanza et al., 1996; Mielke et al., 2004, 2007; Sordet et al., 2004). These
observations indicate that oxidised DNA-bases can indeed trigger
TOP1/2 poisoning in living mammalian cells, although the precise
mechanism of this effect remains unclear.
Besides topoisomerase poisons there also exist compounds that in-
hibit the catalytic activity of TOP1 and/or TOP2 without inducing DNA
breaks. Such catalytic topoisomerase inhibitors affect cells bywithdraw-
ing topoisomerase activity. The most potent catalytic TOP2-inhibitors
are synthetic bisdioxopiperazines such as Dexrazoxane (ICRF 187)
that effectively inhibit cell cycle progression, chromosome condensa-
tion and chromosome segregation (Gorbsky, 1994) by suppressing
TOP2A activity essential for these processes (Christensen et al., 2002b;
Grue et al., 1998; Linka et al., 2007). Similar properties have been
demonstrated in napthoquinone metabolites of natural compounds
from walnut (Jimenez-Alonso et al., 2008) and in anthocyanidins such
asDelphinidin, natural constituents of red coloured fruits that are highly
enriched in food supplements based thereon. All these substances
inactivate TOP2 at μM concentrations without inducing DNA cleavage
(Habermeyer et al., 2005; Kalfalah et al., 2011). Anthocyanidins also
act as catalytic inhibitors of TOP1 (Habermeyer et al., 2005) and strong
catalytic TOP1-inhibitory activity has also been observed in compounds
derived from bioﬂavonoids contained in nuts and coffee (Boege et al.,
1996).
Many substances that poison nuclear topoisomerases also target
mitochondrial topoisomerases (de la Loza and Wellinger, 2009; Lin
and Castora, 1991; Rowe et al., 2001; Zhang and Pommier, 2008),
which possibly plays a role in chronic degeneration of certain tissues.
For instance, myocardial degenerative side effects of anthracyclines
are mediated by poisoning of TOP2B, which is accompanied by a selec-
tive alteration in the transcriptome related to oxidative phosphorylation
and mitochondrial biogenesis (Zhang et al., 2012). The restriction of
damage to themito-biogenic gene programme suggests that mitochon-
drial TOP2B probably is the primordial mediator of the myocardial
degenerative effect. If nuclear TOP2Bwere the target, onewould expect
damage in gene programmes typically regulated in the nucleus by
TOP2B (Tiwari et al., 2012). Mitochondrial topoisomerases may not
only be relevant targets and/or crucially affected bystanders of topo-
isomerase poisoning, but also seem to have a sensitivity spectrum
different from their nuclear counterparts. For instance, they are targeted
by quinolones. Quinolones are clinically established antibiotics that act
through poisoning bacterial TOP2 (gyrase) but do not target the
isoforms of mammalian TOP2 found in the nucleus. Nevertheless, quin-
olones deplete mtDNA (Castora et al., 1983) and induce protein-
mediated mtDNA breaks (Lawrence et al., 1996; Li and Liu, 1998) in
mammalian cells. One possible explanation for this observation is that
loss of the N-terminal domain renders TOP2B sensitive to quinolones
inmammalianmitochondria, while full length TOP2B present in the nu-
cleus is resistant to gyrase inhibitors. On the other hand, there maywell
exist another, as yet unknown, mitochondria-dedicated mammalian
type II topoisomerase that shares sufﬁcient similarities with bacterial
gyrase to be sensitive to quinolones.It must be assumed that normal human life encompasses a certain
level of constitutive topoisomerase poisoning due to the dietary intake
of bioﬂavonoids such as Genistein (Nielsen and Williamson, 2007;
Ross and Kasum, 2002) and the inadvertent exposure to industrial
waste and pharmaceuticals giving rise to benzoquinone metabolites
(Bender et al., 2004; Lindsey et al., 2005) or fungal TOP2-poisons such
Alternariol that are obligatory food contaminants (Fehr et al., 2009). It
is currently assumed that such chronic low-dose exposure of gravid
mothers contributes to the incidence of infant leukaemia (Lindsey
et al., 2005; Ross, 2000; Strick et al., 2000). One should entertain the
idea that it also (and more signiﬁcantly) contributes to chronic
mtDNA attrition associated with ageing. Moreover, established oxida-
tive processes of chronic mtDNA attrition are interlinked with
topoisomerase-mediated mtDNA-damage, inasmuch asmuch as oxida-
tive DNA base modiﬁcations such as 8-oxoguanine, known to trigger
DNA cleavage through topoisomerase I and II (Daroui et al., 2004;
Kingma and Osheroff, 1998; Lanza et al., 1996; Mielke et al., 2004,
2007; Pourquier et al., 1999; Sordet et al., 2004), are much more
frequent in mtDNA than in nuclear DNA (Hoffmann et al., 2004;
Richter, 1995). Although oxidised nucleotides can be effectively
repaired in mtDNA, there is evidence that they are a major source of
double strand breaks (David et al., 2007). In mouse muscle such breaks
promote large mtDNA deletions similar to those found in humans
(Srivastava andMoraes, 2005). In summary these observations support
the hypothesis that topoisomerase-mediated DNA-breaks indeed
contribute to age-related mtDNA attrition.
2.2. Unbalancing of mitochondrial/nuclear transcription by oxidative
inactivation, catalytic inhibition or inadequate expression of TOP1MT
Four of the ﬁve respiratory chain complexes are composed of a mix
of nuclear and mtDNA-encoded components and become unstable
when the stoichiometry of these components is disrupted. Consequent-
ly, nuclear and mitochondrial transcriptions have to be efﬁciently
coordinated. Several proteins involved in that coordination have a
notable impact on lifespan and are involved in age-relatedmitochondri-
al disorders (Finley and Haigis, 2009). Currently, mitochondrial/nuclear
coordination of transcription is mostly assigned to retrograde signalling
loops, through which the mito-biogenic programme in the nucleus can
be activated by dysfunctional or overworked mitochondria via the
release of Ca2+ (Rohas et al., 2007), ROS (Cunningham et al., 2007) or
insufﬁcient ATP-production (Jager et al., 2007). Given the coupling of
mtDNA transcription and replication (Falkenberg et al., 2007), these
mechanisms also control the amount of mtDNA in the cell, which
ultimately adapts energy production to requirements (Rocher et al.,
2008). In addition, there exist mechanisms of direct regulation of
mtDNA transcription allowing for an adjustment of the respiratory
stoichoimetry to the local reduction state at the inner mitochondrial
membrane (Enriquez et al., 1999), which are considered the most
plausible reasons for mitochondria to retain any genes at all (Allen,
1993; Lane, 2014). Redox-sensitive mitochondrial transcription factors
that could possibly perform such a local regulatory function have not
been identiﬁed yet, although there is ample indirect evidence of their
action (Enriquez et al., 1999). There is a strong case for TOP1MT being
one of those hitherto elusive factors. We have shown that TOP1MT
acts as a dominant negative regulator of mtDNA transcription and this
function requires the enzyme to be active in terms of relaxation of
DNA supercoils (Sobek et al., 2014). It has long been known that TOP1
activity is liable to attack by thiol-reactive compounds on essential cys-
teine residues within the enzyme core (Montaudon et al., 2007), which
are conserved in TOP1MT (Zhang et al., 2001, 2004). Plant
mitochondrial topoisomerase I is inactivated by thiol-reactive com-
pounds and oxidised glutathione (Konstantinov et al., 2001). Our own
unpublished experiments in vitro and in organello indicate that this
also holds true for human TOP1MT. Most notably, TOP1MT becomes
inactivated in the living cell, when superoxide levels within the
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summary these observations support the model of a double negative
loop, by which TOP1MT directly regulates mtDNA-transcription in a
redox-sensitive fashion, as schematized in Fig. 1. We propose that
increases in intra-mitochondrial reductive potential (e.g. due to
overloading or dysfunction of the respiratory chain) attenuate TOP1mt
activity through oxidation of essential cysteine residues in the enzyme
core. Alternatively, aberrant di-sulphide bridges between these residues
could be induced by oxidised glutathione. Direct or indirect oxidative
inactivation of TOP1MT then interrupts the repressive effect of the
enzyme on the transcription machinery, thus increasing oxidative
capacity (Sobek et al., 2014).
The above mechanism may play a role in the local adaptation of
respiratory capacity in cases where the energetic demand is not
homogeneously distributed within the cell body such as in liver cells
and neuron cells with long axons (Enriquez et al., 1999). For such
adaptive effects to act beneﬁcially it is required that enhanced mito-
chondrial transcription following TOP1MT inactivation triggers corre-
sponding increases in the transcription of nuclear encoded respiratory
subunits. The mechanism is bound to become mal-adaptive, when
retrograde regulation of the mito-biogenic response in the nucleus
becomes defective. This is typically the case in agedmammalian skeletal
muscle exhibiting a defective retrograde mito-biogenic response due to
dysfunctions of AMPKα2, components of the mTOR pathway (Li et al.,
2012; Qiang et al., 2007) and declining intracellular NAD+ (Gomes
et al., 2013). One would expect that in the latter situation, redox-
sensitive local up-regulation ofmtDNA-transcriptionwill cause a dissoci-
ation of nuclear andmitochondrial transcription leading to an imbalance
between respiratory complexes containingmtDNAencoded components
and respiratory complexes entirely made up of nuclear encoded sub-
units. A similar imbalance would be expected, when there is too much
TOP1MT activity expressed. We have demonstrated that overexpression
of TOP1MT in human cells lowered mitochondrial transcripts, depleted
respiratory complexes I, III and IV, decreased cell respiration and raised
superoxide levels (Sobek et al., 2014), which demonstrates that an inad-
equate increase in TOP1MT activity indeed has the potential to induce
mitochondrial dysfunctions. Imbalance of respiratory complexes due to
selective loss of mtDNA-encoded respiratory subunits has recently
been observed in ageing skeletal muscle, where declining NAD+ induces
a pseudo-hypoxic state through altered expression of c-Myc-regulated
mitochondrial genes (Gomes et al., 2013), one of which is TOP1MT
(Zoppoli et al., 2011). These observations suggest that inadequate
TOP1MT expression/activity could indeed contribute to age-associated
imbalances in the expression of nuclear andmtDNA encoded respiratory
subunits inmammalian tissues. It shouldﬁnally be noted that inadequate
TOP1MT activity could also be due to habitual chronic exposure to cata-
lytic TOP1 inhibitors such as Naphtoquinones or Anthocyanidins possibly
contained in food supplements (see section 2.1).
2.3. Role topoisomerases in age-related increases of recombination and
intertwinement of mtDNA
mtDNA is in principle a double-stranded DNA-circle. However,
based on this structure, it can assume topologies ranging from simpleFig. 1. Double negative feedback loop of redox-sensitive regulation of mtDNA transcrip-
tion by TOP1MT.supercoiled circular monomers and linear intermediates to head-to-
tail circular dimers, intertwined circles, and complex multimeric net-
works interconnected by holiday junctions and entanglements
(Pohjoismaki and Goffart, 2011) aswell as DNA/RNA hybrids and varie-
ty of single stranded DNA molecules (Kolesar et al., 2013). The most
complex, branched andmultiple-entangled forms ofmtDNAare typical-
ly found in adult human post-mitotic organs that have a constantly high
energy demand, i.e. brain and myocardium (Kajander et al., 2001;
Pohjoismaki et al., 2009). In rodents and young humans these same tis-
sues exhibit a simplemonomeric circularmtDNA-topology (Pohjoismaki
et al., 2010). The adult-type branched form ofmtDNA is acquired early in
life and leads to an increase in copy number (Pohjoismaki et al., 2010). It
is unclear, whether that age-related complexity switch in mtDNA topol-
ogy constitutes an adaptive or developmental process (Pohjoismaki and
Goffart, 2011; Pohjoismaki et al., 2010), or the ﬁrst step in a sequence of
recombination and faulty repair driving chronic mtDNA attrition during
ageing (Kajander et al., 2001; Krishnan et al., 2008). The mechanisms
leading to the complex mtDNA topology in aged human myocardium
are multifactorial and not completely understood (Pohjoismaki and
Goffart, 2011). However, these complex mtDNA topologies, namely
multiple intertwined circles and Holliday junctions, exhibit features
suggesting that topoisomerases are involved in their formation.
Each round of replication of a closed circular DNAmolecule inadver-
tently generates a set of intertwined daughtermolecules, the separation
of which requires a type II topoisomerase capable of passing both
strands of the DNA double helix through another double helical DNA
segment (Marini et al., 1980). Separation of intertwined mtDNA mole-
cules may also be catalysed by a type I topoisomerase enabling sequen-
tial passage of single DNA strands through each other (Brown and
Cozzarelli, 1981; Tse and Wang, 1980), but the latter reaction requires
high substrate concentrations not provided in nucleoids containing on
average just one mtDNA molecule (Kukat et al., 2011). Therefore, it is
probably a type II topoisomerase that controls the state of mtDNA inter-
twinement in vivo. TOP2B is the only type II topoisomerase so far found
in mammalian mitochondria (Low et al., 2003). However, TOP2B is not
essentially involved in mtDNA maintenance (Sobek et al., 2014),
suggesting that at least one more type II topoisomerase controls the
state of mtDNA intertwinement. This other type II topoisomerase
could be an unknown, mitochondria-dedicated protein that possibly
shares similarities with bacterial gyrase (see 2.1), or it could be
TOP2A, which is the only other known type II topoisomerase present
in mammals. So far, TOP2A has not been detected in mitochondria and
artiﬁcial targeting of TOP2A to mitochondria leads to rapid mtDNA de-
pletion (our own unpublished observation). However, even if TOP2A
should be the enzyme providing the elusive activity catalysing the
separation of intertwined mtDNA molecules, then this activity would
be available only in proliferative tissues, since TOP2A is expressed
from a single gene, which is tightly repressed in non-proliferative cells
and tissues (Isaacs et al., 1996; Turley et al., 1997). To our knowledge
there exists no alternative transcriptional control of TOP2A that would
allow for an expression in non-proliferative tissues, and the expression
of TOP2A protein is tightly restricted to proliferative cells, tissues and
tissue compartments (Kreipe et al., 1993; Meyer et al., 1997; Turley
et al., 1997). Therefore, age-related increases inmtDNA intertwinement
observed in old, non-proliferative tissues could reﬂect a lack of TOP2A,
which leads to the gradual accumulation of intertwined mtDNA
molecules in the course of ongoing mitochondrial replication. This
would be a degenerative process. Alternatively, enhanced entanglement
of mtDNA could be an adaptive process that increases the number of
mtDNA copies per nucleoid to support age-related increases in energy
demand or compensate increased reductive load and age-related
mtDNA-defects by an increase in redundancy (Pohjoismaki and
Goffart, 2011). Intertwinement of multiple mtDNA molecules would
be a plausible mechanism for condensation and stabilisation of such
larger nucleoidal genomes, given that a very similar mechanism, name-
ly entanglements of sister chromatids, is used in mammals for
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2012; Kawamura et al., 2010; Samejima et al., 2012). A third possible
explanation for the enhanced occurrence of multiple intertwined
mtDNA molecules in old post mitotic tissues is provided by the recent
observation that such structures are increased in mammalian cells
following experimentalmtDNAdepletion, and therefore,may be impor-
tant for supporting conditions of enhanced mtDNA replication (Kolesar
et al., 2013). Finally, it could be imagined that disentanglement of newly
replicated mtDNA circles could be attenuated by habitual chronic
ingestion of catalytic TOP2 inhibitors such as Naphtoquinones or
Anthocyanidins contained at high concentrations in certain food
supplements (see section 2.1).
Another feature of adult-type complex myocardial mtDNA topolo-
gies pointing at an oblique involvement of topoisomerases is the pres-
ence of branched recombination intermediates (Holliday junctions). In
contrast to tetraplasmic maternal/paternal mtDNA recombination
intermediates observed in skeletal muscles of patients with rare D-
loop mutations (Kraytsberg et al., 2004; Zsurka et al., 2005), the
complex mtDNA forms in aged myocardium appear to be the result of
recombination between identical mtDNA molecules. mtDNAmolecules
do not exchange between nucleoids (Gilkerson et al., 2008) and germ
line recombination of mtDNA in the absence of the above mentioned
D-loop mutations is an extremely rare event (Hagstrom et al., 2013).
Therefore, the complex mtDNA forms observed in agedmammalian tis-
sues must arise from somatic recombination of mtDNAmolecules with-
in the same nucleoid. These structures are thought to arise from an
alternative, recombination-driven mode of mtDNA replication and/or
the faulty repair of stalled replication complexes (Pohjoismaki et al.,
2010, 2011). It seems conceivable, that mtDNA polyploidy due to
incomplete separation of intertwined replication products provides an
environment favouring such events or is even a prerequisite thereof.
The incidence of recombination intermediates in mtDNA is closely
associated with the activity of themitochondrial DNA helicase Twinkle,
which is essential for mtDNA maintenance and regulates mtDNA copy
number (Tyynismaa et al., 2004). Twinkle overexpression in mouse
leads to a dramatic increase in complex mtDNA forms containing
Holliday junctions in heart, skeletal muscle and brain (Pohjoismaki
et al., 2009). There exist various catalytically impaired Twinkle muta-
tions associated with recessive hereditary cerebellar dysfunction in
humans (Nikali et al., 2005). Such pathogenic mutations cause Twinkle
to induce mtDNA deletions (Tyynismaa et al., 2005) and replication
stalling (Farge et al., 2008) ultimately leading to complex mtDNA
rearrangements (Pohjoismaki et al., 2011) and late onset mitochondrial
disease in mouse (Tyynismaa et al., 2005). Surprisingly, humans
harbouring such pathogenic Twinkle mutations lack Holliday junctions
in myocardial mtDNA (Pohjoismaki et al., 2010). In summary, these ob-
servations suggest that mtDNA recombination is determined by Twin-
kle in concert with an as yet unidentiﬁed cofactor that complements
or enhances dysfunctions of the helicase in a variable manner. The situ-
ation is reminiscent of the role of RecQ helicases in nuclear DNA-
recombination associated with replication stalling. Mutations in three
members of this enzyme family are associated with genome instability
in human progeroid syndromes (Bloom's, Werner's and Rothmund-
Thomson's syndrome) (Hanada and Hickson, 2007; Wu and Hickson,
2001). The RecQ helicase involved in Bloom's syndrome forms stable
complexes with TOP3A, and interaction of these two classes of proteins
is required to maintain genomic stability by preventing inappropriate
recombination in all eukaryotic species where this has been studied
(Wu and Hickson, 2001; Wu et al., 2000). Most notably, the complex
of Bloom's helicase and TOP3A is the most potent resolvase of Holliday
junctions in the nuclear genome (Hickson and Mankouri, 2011). Given
that Holliday junctions have been observed in mitochondria and no
other enzyme that could resolve these structures has yet been found
in the organelle, it seems a plausible surmise that Twinkle is the mito-
chondrial equivalent of Bloom's helicase and likewise cooperates with
TOP3A to resolve Holliday junctions in mtDNA. Under this premise,enhanced mtDNA recombination in aged human myocardium could
be due to an altered balance of helicase and topoisomerase activity.
Incidentally, that mechanism could well be responsible for the loss of
mtDNA observed in TOP3A deﬁcient Drosophila (Wu et al., 2010).
3. Concluding remarks
Theoretical considerations suggest that DNA topoisomerases are as
essential for mtDNA maintenance and function, as they are for corre-
sponding processes in the cell nucleus. A number of observations indi-
cate that dysfunction or exogenous disruption of these enzymes could
be involved in chronic mtDNA attrition and age-related decline of
mtDNA homeostasis. This possibility has so far not been systematically
investigated. Inclusion of DNA topoisomerase into current concepts on
mitochondrial ageing processes could help to understand hitherto
unclear phenomena and observations in the age-related decline of
mtDNA homeostasis.
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